Equity Profile
Post-Earnings Recap
Halozyme Therapeutics, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.16 | $-0.17 | +32.49% |
| Revenue | N/A | $50M | N/A |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HeartFlow, Inc. is a health care technology company focused on improving cardiovascular care through advanced imaging and analysis....
EPS
Earnings per share (EPS) is a key indicator of profitability and will show how well the company is managing its costs.
Revenue
Revenue figures will provide insight into the company's sales performance and market demand for its technology.
Wall Street expectations, options signals, track record, and call prep available with Pro.